Literature DB >> 8978746

Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15.

J L Montiel1, F Cornille, B P Roques, F Noble.   

Abstract

The endogenous opioid receptor-like1 (ORL1) ligand, nociceptin/orphanin FQ (FGGFTGARKSARKLANQ), a heptadecapeptide structurally resembling dynorphin A, has recently been identified. The wide distribution of ORL1 mRNA and nociceptin/orphanin FQ precursor in the CNS, particularly in the limbic system regions and in several areas known to be involved in pain perception, suggests that nociceptin/orphanin FQ is potentially endowed with various central functions. In general, activation and/or inactivation of regulatory peptides occur through the action of cell surface peptidases. The physiological mechanisms under which nociceptin/orphanin FQ is metabolized should lead to a better understanding of its physiological functions. Mouse brain cortical slices were incubated in medium containing the heptadecapeptide in the presence or in the absence of peptidase inhibitors. The critical sites of enzymatic cleavage are Phe1-Gly2, Ala7-Arg8, Ala11-Arg12, and Arg12-Lys13 bonds. The major role played by metallopeptidases was confirmed by the complete protection of metabolism in the presence of EDTA. Aminopeptidase N and endopeptidase 24.15 are the two main enzymes involved in nociceptin/orphanin FQ metabolism, whereas endopeptidase 24.11 (involved in enkephalin [YGGFM(L)] catabolism) does not appear critically involved in nociceptin/orphanin FQ metabolism. The physiological relevance of aminopeptidase N and endopeptidase 24.15 in the heptadecapeptide metabolism remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8978746     DOI: 10.1046/j.1471-4159.1997.68010354.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

1.  The Drosophila slamdance gene: a mutation in an aminopeptidase can cause seizure, paralysis and neuronal failure.

Authors:  HaiGuang Zhang; Jeff Tan; Elaine Reynolds; Daniel Kuebler; Sally Faulhaber; Mark Tanouye
Journal:  Genetics       Date:  2002-11       Impact factor: 4.562

2.  [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats.

Authors:  J P Redrobe; G Calo; R Guerrini; D Regoli; R Quirion
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Intracellular peptides as natural regulators of cell signaling.

Authors:  Fernanda M Cunha; Denise A Berti; Zulma S Ferreira; Clécio F Klitzke; Regina P Markus; Emer S Ferro
Journal:  J Biol Chem       Date:  2008-07-10       Impact factor: 5.157

4.  Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.

Authors:  T Sakurada; S Katsuyama; S Sakurada; M Inoue; K Tan-No; K Kisara; C Sakurada; H Ueda; J Sasaki
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 5.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

6.  Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin.

Authors:  S Sbrenna; M Marti; M Morari; G Calo'; R Guerrini; L Beani; C Bianchi
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

7.  [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.

Authors:  L C Chiou
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

8.  Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices.

Authors:  A Siniscalchi; D Rodi; L Beani; C Bianchi
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

9.  Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro.

Authors:  S Werthwein; U Bauer; M Nakazi; M Kathmann; E Schlicker
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

10.  Analysis of intracellular substrates and products of thimet oligopeptidase in human embryonic kidney 293 cells.

Authors:  Denise A Berti; Cain Morano; Lilian C Russo; Leandro M Castro; Fernanda M Cunha; Xin Zhang; Juan Sironi; Clécio F Klitzke; Emer S Ferro; Lloyd D Fricker
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.